Adverse effects and relapse rate in patients with inflammatory bowel disease taking azathioprine versus 5-ASA and azathioprine

被引：0
|
作者：
Shah, JA [1 ]
Edwards, CM [1 ]
Probert, CS [1 ]
机构：
[1] Torbay Hosp, Bristol Royal Infirm, Torquay, England
来源：
GUT | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
306
引用
收藏
页码：A80 / A80
页数：1
相关论文
共 50 条
  • [31] Azathioprine/6-mercaptopurine versus 5-aminosalicylic for treatment of inflammatory bowel disease
    Chen, Xin-Lin
    She, Shi-Feng
    Li, Yu-Huang
    Zhang, Wei-Jian
    Tang, Ying-Ting
    Zhuang, Kun-Hai
    Pan, Yun-Bao
    Liu, Feng-Bin
    He, Wei-Ling
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 1927 - 1936
  • [32] Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse
    Iborra, Marisa
    Herreras, Julia
    Maia Bosca-Watts, Marta
    Cortes, Xavier
    Trejo, Galo
    Cerrillo, Elena
    Hervas, David
    Minguez, Miguel
    Beltran, Belen
    Nos, Pilar
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (06) : 1612 - 1621
  • [33] Comparison of Standard Dose Azathioprine Versus Low Dose Azathioprine When Used as Adjuvant Therapy with Infliximab in Patients with Inflammatory Bowel Disease
    Harper, Jason
    Zisman, Timothy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S628 - S629
  • [34] Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome
    Shah, Jayshri A.
    Edwards, Cathryn M.
    Probert, Chris S.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (03) : 169 - 173
  • [35] Azathioprine treatment in inflammatory bowel disease patients: type and time of onset of side effects
    Avallone, E. V.
    Pica, R.
    Cassieri, C.
    Zippi, M.
    Paoluzi, P.
    Vernia, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (02) : 165 - 170
  • [36] Safety of chronic 5-ASA use in the elderly inflammatory bowel disease population
    Sommer, Camille
    Feldstein, Richard
    Raju, Shanti
    Mastrine, Lou R.
    Katz, Seymour
    GASTROENTEROLOGY, 2008, 134 (04) : A661 - A661
  • [37] 5-ASA and Chemoprevention in Inflammatory Bowel Disease: A Population-Based Analysis
    Dorreen, Alastair
    Stewart, Samuel A.
    Lix, Lisa
    Jones, Jennifer
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S284 - S285
  • [38] THE USE OF 5-ASA IN INFLAMMATORY BOWEL DISEASE: NATIONAL POPULATION BASED STUDY
    Chhaya, V.
    Saxena, S.
    Cecil, E.
    Subramanian, V.
    Curcin, V.
    Majeed, A.
    Pollok, R.
    GUT, 2015, 64 : A444 - A444
  • [39] The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD)
    Shim, Lisa
    Eslick, Guy D.
    Simring, Alexander A.
    Murray, Henry
    Weltman, Martin D.
    JOURNAL OF CROHNS & COLITIS, 2011, 5 (03): : 234 - 238
  • [40] Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine
    Vernier-Massouille, G.
    Cosnes, J.
    Lemann, M.
    Marteau, P.
    Reinisch, W.
    Laharie, D.
    Cadiot, G.
    Bouhnik, Y.
    De Vos, M.
    Boureille, A.
    Duclos, B.
    Seksik, P.
    Mary, J-Y
    Colombel, J-F
    GUT, 2007, 56 (10) : 1404 - 1409
12345